Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Emyria Ltd ( (AU:EMD) ) has provided an update.
Emyria has signed a landmark agreement with Avive Health to establish an Empax clinic in Brisbane, marking its first location in Queensland. This expansion is part of Emyria’s national rollout strategy to deliver specialized, reimbursable care for treatment-resistant mental health conditions, leveraging partnerships to scale efficiently and address increasing patient demand. The agreement provides Emyria with exclusive rights to deliver its PTSD and treatment-resistant depression programs at the Brisbane site, with potential expansion into Victoria and South Australia. This move follows a significant agreement with Medibank Private Ltd, enhancing Emyria’s position in the mental health industry and expanding patient access to innovative care.
More about Emyria Ltd
Emyria Limited is a leader in developing and delivering innovative mental health treatments, focusing on specialized care for treatment-resistant mental health conditions. The company is expanding its national footprint by establishing clinics in partnership with private hospitals, aiming to address Australia’s growing mental health crisis.
Average Trading Volume: 2,294,736
Technical Sentiment Signal: Hold
Current Market Cap: A$25.07M
For detailed information about EMD stock, go to TipRanks’ Stock Analysis page.